XBKK
PR9
Market cap513mUSD
Nov 12, Last price
20.80THB
Name
Praram 9 Hospital PCL
Chart & Performance
P/E
22.95
P/S
3.53
EPS
0.91
Div Yield, %
1.44%
Shrs. gr., 5y
—
Rev. gr., 5y
10.23%
Revenues
4.64b
+10.31%
Net income
713m
+27.75%
CFO
1.04b
+29.33%
Dividend
May 07, 20250.25 THB/sh
Notes
No notes on this company yet
Write a private note on this company, for your eyes only
Profile
Praram 9 Hospital Public Company Limited operates a hospital under the Praram 9 Hospital name in Thailand. The company offers a range of tertiary care services, including health promotion, preventive healthcare, diagnosis, treatment, and rehabilitation in the medical areas of obstetrics and gynecology, surgery, medicine, pediatrics, kidney transplant, cardiovascular, and orthopedics. It also operates diabetes and metabolic, gastroenterology and hepatobiliary, neurology, check-up, emergency, physical therapy and rehabilitation, radiology, eye, ear, nose and throat, dental, mind, skin and cosmetic surgery, breast, joint care, spine, allergy, onco care, sleep, chest and respiratory, wellness, and LASIK centers. The company was founded in 1992 and is based in Bangkok, Thailand.
Valuation
Title THB in thousands, except ratios and share amounts | FY | FY | FY | FY | FY | FY | FY | FY | FY | FY |
|---|---|---|---|---|---|---|---|---|---|---|
| 2024‑12 | 2023‑12 | 2022‑12 | 2021‑12 | 2020‑12 | 2019‑12 | 2018‑12 | 2017‑12 | 2016‑12 | 2015‑12 | |
| Income | ||||||||||
Revenues | ||||||||||
Cost of revenue | ||||||||||
Unusual Expense (Income) | ||||||||||
NOPBT | ||||||||||
NOPBT Margin | ||||||||||
Operating Taxes | ||||||||||
Tax Rate | ||||||||||
NOPAT | ||||||||||
Net income | ||||||||||
Dividends | ||||||||||
Dividend yield | ||||||||||
Proceeds from repurchase of equity | ||||||||||
BB yield | ||||||||||
| Debt | ||||||||||
Debt current | ||||||||||
Long-term debt | ||||||||||
Deferred revenue | ||||||||||
Other long-term liabilities | ||||||||||
Net debt | ||||||||||
| Cash flow | ||||||||||
Cash from operating activities | ||||||||||
CAPEX | ||||||||||
Cash from investing activities | ||||||||||
Cash from financing activities | ||||||||||
FCF | ||||||||||
| Balance | ||||||||||
Cash | ||||||||||
Long term investments | ||||||||||
Excess cash | ||||||||||
Stockholders' equity | ||||||||||
Invested Capital | ||||||||||
ROIC | ||||||||||
ROCE | ||||||||||
| EV | ||||||||||
Common stock shares outstanding | ||||||||||
Price | ||||||||||
Market cap | ||||||||||
EV | ||||||||||
EBITDA | ||||||||||
EV/EBITDA | ||||||||||
Interest | ||||||||||
Interest/NOPBT | ||||||||||